PRELIMINARY EFFICACY AND MOLECULAR CHARACTERIZATION OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS WITH FLT3 MUTATION TREATED WITH SINGLE AGENT EMAVUSERTIB (CA-4948)

Venclexta (venetoclax) - Roche, AbbVie

emavusertib (CA-4948) - Curis, Dr. Reddy’s

https://library.ehaweb.org/eha/2024/eha2024-congress/420618/eric.winer.preliminary.efficacy.and.molecular.characterization.of.relapsed.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29192%2Amarker%3D5101%2Afeatured%3D18527

Eric Winer; Naval Daver; Daniel J. DeAngelo; Amit K. Verma; Stefanie Gröpper; Katharina Götze; Yasmin Abaza; Jan-Henrik Mikesch; Gaurav Choudhary; Maureen Lane; Mariano Severgnini; Wanying Zhao; Ashish Jain; Cole Gallagher; Reinhard von Roemeling; Guillermo Garcia-Manero

May 15, 2024